Literature DB >> 3111037

Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor.

E Vilmer, A Rhodes-Feuillette, C Rabian, M Benbunan, J Meletis, A Devergie, J H Bourrhis, J C Gluckman, J C Chermann, E Gluckman.   

Abstract

The diagnosis of transfusion-associated acquired immunodeficiency syndrome (AIDS) was made in 2 patients who developed delayed opportunistic infections and severe cytopenias--56 months for the former (patient 1) and 22 months for the latter, (patient 2) following bone marrow transplantation (BMT) for aplastic anemia. In the third case, grafting for acute leukemia (patient 3) (HIV) infection was probably responsible for the failure of hematological and immunological reconstitution 8 months after allogeneic BMT. Each patient received 6 lymphocyte transfusions from the marrow donor for 3 weeks, combined with a 3-month course of low-dose recombinant alpha interferon. This treatment was followed by recombinant gamma interferon for 3 months. We showed that these 3 patients could resume a normal life for 9 months, at least, and that hematological restoration was observed. Our treatment succeeded in correcting the defect of proliferative response to Candida and the impairment of gamma interferon generation for 4 months in one patient and for more than 12 months in the other two recipients. Nevertheless T4 lymphocyte levels increased only slightly and HIV can still be isolated from the patients' blood. At the time of writing, patients 1 and 3 remain in good health with a partial immunological restoration while patient 2 has died of neurological impairment 2 years after the AIDS diagnosis. Although we cannot generalize this successful therapeutic approach to all patients with AIDS, the results may provide an interesting model of the potential effect of lymphocyte transfusions and the role of interferon therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111037     DOI: 10.1097/00007890-198707000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.

Authors:  Ann E Woolfrey; Uma Malhotra; Robert D Harrington; John McNevin; Thomas J Manley; Stanley R Riddell; Robert W Coombs; Frederick R Appelbaum; Larry Corey; Rainer Storb
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

Review 2.  Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years.

Authors:  G Hütter; J A Zaia
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

Review 3.  HIV cure strategies: which ones are appropriate for Africa?

Authors:  Christopher Zaab-Yen Abana; Helena Lamptey; Evelyn Y Bonney; George B Kyei
Journal:  Cell Mol Life Sci       Date:  2022-07-06       Impact factor: 9.207

4.  Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies.

Authors:  Christine Johnston; Robert Harrington; Rupali Jain; Joshua Schiffer; Hans-Peter Kiem; Ann Woolfrey
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-08       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.